BioCentury
ARTICLE | Company News

Memory acquires Bayer compound

September 11, 2001 7:00 AM UTC

Memory (Montvale, N.J.) obtained exclusive worldwide rights from Bayer (FSE:BAYG) to MEM 1003, a neuronal calcium channel modulator, to treat dementia. Memory will pay upfront fees plus milestones and...